Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.
Joining us today is Rob Etherington, CEO of Clene Nanomedicine.
Rob brings over 30 years of experience in pharma, including 8 years at Parke-Davis, 13 years at Actelion-where he was part of the team that took the company public-and now, 11 years leading Clene.
At Clene, he's at the forefront of using nanotechnology to tackle neurodegenerative diseases.
Enjoy and stay tuned!